13 results - M - W - D

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

#f

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

10/29/25 10:13
10/27/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticBorel James CMID3M.d355.9906696D
10/29/25 10:08
10/27/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticCapello Jeffrey DMID3M.d355.99062233D
10/29/25 10:06
10/27/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticGreen Ronald DMID2M.d235.89042619D
10/29/25 10:03
10/27/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticGupta AashimaMID2M.d235.89041628D
10/28/25 15:51
10/27/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticRodriguez Rafael AMID2M.d235.89042321D
10/28/25 15:48
10/27/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticTobin James PMID2M.d235.89041043D
10/28/25 15:39
10/27/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticWoteki Catherine EMID2M.d235.89042519D
10/28/25 13:57
10/27/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticRocklin Amy MMIOGC4M.d1655.6602910457D
10/28/25 13:46
10/27/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticNaemura David H.MIOCFO2M.d1745.830305881D
10/28/25 13:36
10/27/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticJones Douglas EdwardMIOFormer C4M.d2515.7704476101D
10/28/25 13:27
10/27/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticAdent John EdwardMIOFormer C4M.d6385.77011044363D
10/28/25 13:12
10/27/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticBoehm William TMID2M.d335.91061348D
8/20/25 10:23
8/18/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticMoylan John PatrickMIOChief Ac1M.d115.43021614D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact